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Abstract
In septic patients increased central drive and increased metabolic
demands combine to increase energy demands on the ventilatory
muscles. This occurs at a time when energy supplies are limited
and energy production hindered, and it leads to an energy supply-
demand imbalance and often ventilatory failure. Problems related
to contractile function of the ventilatory muscles also contribute,
especially when the clinical course is prolonged. The increased
ventilatory activity increases interactions between the ventilatory
and cardiovascular systems, and when ventilatory muscles fail and
mechanical ventilatory support is required a new set of problems
emerges. In this review I discuss factors related to ventilatory
muscle failure, giving emphasis to mechanical and supply demand
aspects. I also review the implications of changes in ventilatory
patterns for heart-lung interactions.
Introduction
Abnormalities of ventilation are an important part of the septic
syndrome [1], and an understanding of the pathophysiology
of these disorders is essential in the management of septic
patients. Disorders of ventilation can be broadly classified as
abnormalities related to the following: ventilatory drive; func-
tion of the ventilatory pump, which is dependent upon the
supply of energy, the demand for energy and the intrinsic
function of the muscle; and abnormalities related to the inter-
action of the ventilatory and cardiovascular systems (heart-
lung interactions). In this review I discuss each of these,
giving emphasis to mechanical factors. Some aspects of
these topics were reviewed previously [2-8].
Abnormalities of ventilatory drive
A characteristic of sepsis, and part of the definition of the
systemic inflammatory syndrome, is an increase in respiratory
rate [9]. An increase in respiratory rate can occur with an
increase in total ventilation or with a fall in tidal volume, in
which case there is no change in total ventilation. At least in
the early stages, most often total ventilation increases,
although in later stages the ratio of respiratory rate to volume
usually is increased [10]. If the increase in ventilation in
sepsis were just a response to increased metabolic demands
with an increase in oxygen consumption and production of
carbon dioxide, then the partial pressure of carbon dioxide
(PCO2) would not change, but it often decreases. It is also not
simply compensation for a metabolic acidosis because the
pH in the early stages of sepsis is often above 7.4 [11]. Thus,
the increase in ventilation is a primary event and represents
hyperventilation (ventilation beyond metabolic needs), and a
respiratory alkalosis in a critically ill patient should always
raise suspicion of a generalized inflammatory response.
The specific cause of increased respiratory drive is not known
but cytokines such IL-1β and IL-6 are likely factors. Another
factor is the role played by peripheral afferent nerve fibres
[12] (Figure 1). Vagal afferents exist in the periphery of the
lung that initiate a marked increase in efferent phrenic nerve
activity when the endings of these afferents are stimulated
with simple injections of hypertonic saline [13]. Another reflex
response comes from thin fibre afferents in the diaphragm
and other respiratory muscles [14].
All muscles have thin afferent fibres (type III and type IV
nonmylenated fibres) that respond to mechanical stimuli as
well as noxious metabolic signals such as arachidonic acid
metabolites, increased potassium ions, increased osmolality
and lactate [15,16], and they act on the ventilator area of the
brain stem to increase ventilation and, in particular, respira-
tory frequency [17]. Activation of these afferents in the
diaphragm can result in an important positive feedback loop,
especially in someone with lung disease. The consequent
increased drive to breathe increases the energy consumption
of the diaphragm, which thus increases metabolites in the
diaphragm that further increase the respiratory drive, so that
the process feeds on itself until ventilator muscle failure
occurs. Activation of these afferents also results in increased
activation of the sympathetic nervous system, with conse-
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quent increases in heart rate and peripheral vasoconstriction
[18]. The increased ventilatory drive is suppressed by
narcotics but does not respond very well to benzodiazepines,
which is consistent with increased drive of a central
ventilatory pacemaker site.
Abnormalities of the ventilatory pump
Failure of the ventilatory pump is a central component of
severe sepsis and a major cause of death in sepsis [1]. In
animals treated with lipopolysaccharide (endotoxin), ventila-
tory failure leads to death before circulatory failure if venti-
lation is not supported [19,20] (Figure 2). The pattern is
similar to what is seen in other forms of shock [21-23]. There
is a period of increased ventilation and increased respiratory
work, and then a decline in force generation by the respira-
tory muscles, and eventually respiratory arrest. Importantly,
PCO2 does not usually rise until the animals become apnoeic
[24]. The same pattern most often occurs in patients. Thus,
impending ventilatory failure must be anticipated and acted
upon before PCO2 increases. The decision to provide
mechanical ventilatory support should be based on a pattern
of progressively increasing rate of breathing with falling tidal
volumes (rapid-shallow breathing) and respiratory distress.
When considering the mechanisms, one must consider
problems related to increased ventilatory muscle energy
demands, decreased supply of energy to the ventilatory
muscles and decreased intrinsic muscle function.
Increased energy demands
The energy needs of the ventilatory system are determined by
the tension produced by the respiratory muscles per minute.
Normally, expiration is passive and active expiration is only
required during heavy exercise, so that it is the energy
demands on inspiratory muscles that are the primary deter-
minant of ventilatory failure. The diaphragm is the major
muscle for inspiration and the key to understanding
ventilatory failure in sepsis; intercostal muscles also play a
role in inspiration but to a lesser extent. Importantly, it is not
respiratory work - the product of pressure and volume - but
tension that is the key determinant of diaphragmatic energy
needs. This situation is identical to that of the heart, in which
tension and not work determines cardiac energy needs [25].
The tension in the diaphragm is related to the pressure
across the diaphragm, the fraction of the cycle spent in the
contraction phase (duty cycle) and the number of contractions
per minute (respiratory rate). A value called the ‘pressure-time
index’ (PTI [cmH2O × second/minute]) can be calculated from
the product of the transdiaphramatic pressure (abdominal
pressure - pleural pressure [cmH2O]) and inspiratory time
(seconds), and divided by respiratory frequency (breaths/
minute) [24]. An increase in the ventilatory rate thus increases
the energy demand because it results in more time per minute
in the contraction phase. However, based on measurements
of diaphragmatic blood flow in animals, a large part of the
increase in diaphragmatic energy demands that occurs with
an increase in frequency is independent of the total pressure
per time [26]. This is thought to occur because there is an
‘activation’ energy required to initiate each contraction. The
duty cycle (fraction of time in the contraction phase) usually
remains constant with increases in frequency of contractions,
which means that the inspiratory time decreases with
increases in rate. Thus, a constant tidal volume at an
increased rate requires faster inspiratory flow rates to achieve
the tidal volume. This can significantly increase airway resis-
tance, especially in those breathing through an endotracheal
tube because of the exponential pressure-flow relationship of
these tubes. The sum of these effects means that increased
respiratory rate greatly increases the energy demands of the
diaphragm [27] and explains why rapid-shallow breathing is
such a strong predictor of ventilator failure. It has also been
shown that an increase in transdiaphragmatic pressure
produced by a negative pleural pressure is more energy
costly for the diaphragm than transdiaphragmatic pressure
produced by increasing abdominal pressure [28].
The pressure required to achieve a tidal breath is related to
the airway resistance (and resistance through the external
circuit if the patient is intubated), the elastance (inverse of
compliance) of the lungs and chest wall, and the presence of
any threshold load, which occurs when there is positive end-
expiratory pressure (PEEP), whether this PEEP is intrinsic
(auto-PEEP) or extrinsic. In animals in which lung injury has
been produced with oleic acid there is a large fall in dynamic
Figure 1
Schema of factors involved in increased ventilatory drive. Cytokines,
endotoxin (LPS) and acidaemia produce an initial increase in the drive
to breathe. Demands on the ventilatory muscles (especially the
diaphgram) are also increased by a decrease in dynamic compliance of
the lungs and chest wall. Increased metabolic activity in ventilatory
muscles activates type III and IV afferents, which further increase the
drive to breathe. Lung injury activates vagal afferents that also increase
respiratory drive. Efferent activity from the brain increases sympathetic
activity, which can lead to vasoconstriction and increased heart rate.
See text for further details. LPS, lipopolysaccharide.Page 3 of 12
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compliance, which is related to all three types of loads [29]. It
is likely that a large part of this load is related to airway
closure, and airway recruitment on inspiration is probably a
more important contributor to the threshold load than
changes in elastance of lung tissue [30]. It has also been
shown that in the initial stages of oleic acid induced lung
injury, chest wall compliance does not change [31]. However,
in the clinical setting, in which large amounts of fluids are
often used for resuscitation, or when abdominal pressure is
increased, as in patients with peritonitis, decreased chest
wall compliance can become very important [32,33].
Increased load on the ventilatory system means that the dia-
phragm must generate greater tension to generate a breath. As
the lung injury progresses physiological dead-space also
increases, so that ventilation must increase further to compen-
sate and maintain a normal PCO2 [34]. From an energetic point
of view, an increase in elastic load is best dealt with by
breathing at a rapid rate and small tidal volume, because the
smaller peak pressure required for a smaller tidal volume mini-
mizes the PTI [35]. The increased rate actually occurs naturally
because of factors that increase the drive to breathe, as dis-
cussed above. However, the shallow breaths eventually result
in progressive atelectasis and the person increasingly breathes
around the lower inflection point, which further increases the
respiratory load. With progressive failure of the ventilator pump,
hypoxaemia and acidaemia develop, which lead to a further
decline in ventilator pump function and respiratory failure.
Available online http://ccforum.com/content/13/1/202
Figure 2
(a) The top part of the figure shows the endotoxin induced increase in ventilation in dogs, which then decreases as the animal’s ventilatory muscles
fail. The numbers at the top represent the mean values for PCO2 in septic animals at each stage. Note how stable they remain, even with decreasing
ventilation. The bottom shows the changes in diaphragmatic and intercostal muscle flows that were associated with the changes in ventilation.
Reproduced with permission from Hussain and coworkers [24]. (b) An example of the loss of diaphragmatic endurance in rats treated for 3 days
with Streptococcus pneumoniae. After 3 days phrenic nerves were stimulated at 10 Hz for 30 seconds and transdiaphragmatic pressure (Pdi) was
measured. Single twitches are shown at the beginning and end of 30 seconds of stimulation. There was a marked decrease in tension in septic
animals compared with controls. Reproduced with permission from Boczkowski and coworkers [68].Although the above discussion is sufficient to explain the
ventilator failure of sepsis, it is unlikely that increased venti-
lator demands solely account for ventilator muscle failure. The
ventilatory system has large reserves. At peak exercise total
ventilation in a 75 kg man can reach over 150 l/minute, and
total ventilation of 40 to 50 l/minute can be maintained by
marathon runners for prolonged periods of time. What, then,
is different in the septic patient?
Decreased supply of energy
In the early phase of sepsis limitation in blood flow and
energy supply probably play the major roles, because the
pattern of diaphragmatic failure is similar to that observed in
other types of shock [20-22,36,37]. Sustained muscle func-
tion requires oxygen, so that oxygen delivery is a critical
determinant of diaphragmatic function (Figure 3). Oxygen
delivery is determined by blood flow, the concentration of
haemoglobin and its saturation, which in turn is determined
by the partial pressure of oxygen. Blood flow is determined by
arterial pressure minus the downstream pressure divided by
the resistance to flow in the tissue. In shock of any type there
is, by definition, a fall in arterial pressure, which compromises
flow. This can be compensated for to some extent by
vasodilatation and a decrease in local arterial resistance, but
once vasodilatory reserves are used up flow becomes totally
dependent upon arterial pressure [38,39]. Knowledge of the
lowest resistance of the vasculature of the diaphragm gives
an indication of the highest flow possible at a given pressure,
which accordingly indicates the maximum possible sustain-
able work by the diaphragm. We previously calculated the
maximum vascular conductance in the diaphragm of dogs to
be 3.13 ± 0.56 ml/minute per mmHg per 100 g and the
pressure at zero flow to be 17 mmHg [39]. It has been shown
that the relationship of blood pressure to diaphragmatic flow
is just about at this limit in dogs with septic shock [36] as
well as in dogs in cardiogenic shock and with increased
pulmonary elastance to simulate pulmonary oedema [23].
This supports the argument that a limitation in oxygen delivery
to the ventilatory muscles is an important factor in the
ventilator failure observed in the early stages of sepsis.
Of importance, diaphragmatic blood flow and oxygen delivery
to the diaphragm are dependent upon arterial pressure and
not cardiac output, although the cardiac output along with the
total peripheral resistance determine arterial pressure [40,41].
Severe reductions in cardiac output can result in reflex vaso-
constriction, which could overcome local metabolic signals in
the diaphragm, increase the diaphragmatic vascular resis-
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Figure 3
The relationships of diaphragmatic PTI, oxygen consumption, blood flow and arterial blood pressure. (a) The linear relationship between PTI and
oxygen consumption. (b) The linear relationship between oxygen consumption and blood flow, which is seen in all muscles. (c) The pressure flow
lines for different vascular conductances (1/resistance). The steepest line indicates maximum conductance (minimum resistance) and thus the
highest possible flow for any given blood pressure. (d) Maximum PTI is determined by the maximum flow at a given blood pressure. The dotted line
in panels a to c shows the maximum flow for that blood pressure that gives the maximum oxygen consumption for that blood pressure, and
therefore the maximum sustainable PTI for that blood pressure. BP, blood pressure; PTI, pressure time index; Q-musc, blood flow; VO2-musc,
oxygen consumption.tance and decrease diaphragmatic blood flow. Similarly, high
doses of vasoconstrictors such as norepinephrine (nor-
adrenaline) can compromise diaphragmatic flow [42]. On the
other hand, profound hypotension due to a generalized loss
of vascular tone, even with high values of cardiac output, can
result in inadequate diaphragmatic blood flow. Under this
condition the excess blood flow is effectively shunted through
sites of low metabolism, and it is possible that restoring some
vascular tone with moderate doses of vascoconstrictors will
improve diaphragmatic blood flow because the local
metabolic activity will help to maintain a selectively lower
vascular resistance in the working diaphragm.
Other factors apart from arterial pressure also can com-
promise diaphragmatic blood flow. At diaphragmatic tensions
that are greater than 30% of peak tension, diaphragmatic
flow is obstructed during the contraction phase and flow can
only occur during the relaxation phase [43]. This is especially
true when the arterial pressure falls, because there is less
driving pressure to overcome the tension on the vessels from
the contracting muscle [44]. When ventilator frequency
increases to the 30 to 40 breaths/minute range, the relaxation
time can become sufficiently shortened so that there is not
enough time to perfuse the diaphragm properly.
Normally, there is a linear relationship between the PTI of the
diaphragm and diaphragmatic oxygen consumption [23]
(Figure 3). Because blood flow is linearly related to oxygen
consumption, there is also a linear relationship of diaphrag-
matic blood flow to PTI [23,29]. However, when lung injury
occurs in sepsis there is progressive hypoxaemia and a fall in
arterial oxygen content and oxygen delivery. To compensate,
diaphragmatic flow must increase [29] but this can only occur
if there are flow reserves, as discussed above. A failure to
increase flow will lead to further dysfunction of the ventilatory
system and progression of respiratory muscle failure. The
limitation in oxygen delivery is especially a problem for the
respiratory muscles, because their oxygen need is increased
as a result of the increasing demands on the respiratory
muscles, and their failure contributes to the hypoxaemia.
A potential consequence of the imbalance between oxygen
supply and demand in the respiratory muscles is the
development of what is called muscle fatigue, which is
characterized by a failure of motor output for a given neural
input and, importantly, is relieved only by rest. In other words,
once the muscle fails because of fatigue, a period of rest is
required before force can once again be generated by the
muscle [20,45,46]. However, it is not clear how often true
muscle fatigue actually occurs, and the ventilatory muscles
more often fail because the workload becomes too great for
their potential output [47].
It is clear that supporting a septic patient with mechanical
ventilation prevents death from ventilator failure, but the use
of mechanical ventilation has further therapeutic value. The
increased work by ventilatory muscles in patients with
respiratory distress requires high oxygen consumption to
maintain this activity, and accordingly more blood flow. The
needs of the ventilatory muscles thus could potentially con-
sume a large proportion of the available oxygen, especially
under conditions of limited blood flow. One study [48]
estimated that the respiratory muscles take up as much as
24% of oxygen consumed by the body in patients with
respiratory distress, even though the total ventilation was in
the range of 9 l/minute and thus normal. This value was
obtained by comparing oxygen consumption before and after
the onset of mechanical ventilation. The investigators argued
that mechanical ventilation would therefore leave more
oxygen to be consumed per minute by the rest of the body,
which could be especially important in patients with limited
cardiac function. However, the estimate of oxygen consump-
tion by the ventilatory muscles was probably an overestimate
because it would have included excess sympathetic activity
associated with the respiratory distress.
Subsequent animal studies further tested this issue. These
studies showed that mechanically ventilating animals sub-
jected to cardiogenic shock decreased respiratory muscle
blood flow, and this was associated with an increase in flow
to the brain and kidney [22,37]. The same was true in sepsis
[36]. It was initially thought that the lower blood flow to vital
organs with spontaneous breathing was due to a ‘steal
phenomenon’, in that the vascular resistance in the working
ventilator muscles falls and diverts the limited blood flow from
vital organs to the ventilatory muscles [22]. In a study with
markedly increased ventilator activity caused by oleic acid
induced lung injury but normal cardiac function [29], total
ventilator muscle flow accounted for 11% of total cardiac
output, and oxygen consumption would be expected to follow
a similar proportion of the total. In a model of cardiogenic
shock but unobstructed lungs, ventilatory muscles accounted
for 20% of cardiac output [22]. However, when cardiogenic
shock was combined with increased elastic load, ventilatory
muscle blood flow accounted for only 8% of the total blood
flow, probably because the more forceful muscle contraction
began to limit flow and possibly because the muscles were
beginning to fail [23]. Similarly, in a dog model of septic
shock with a low cardiac output, ventilatory muscles accoun-
ted for 9% of blood flow [36].
Taken together, these studies indicate that unless there is a
profound decrease in cardiac output, the energy and flow
needs of the diaphragm do not have a major impact on other
organs, although limitations in the ventilatory muscles them-
selves can have major consequences for the whole organism.
If vital organs become ischaemic, then it would be expected
that their local metabolic factors would dilate their local
vascular resistance vessels and help to maintain their
proportion of total blood flow, because the relationship of
pressure to resistance determines the distribution of flow
[39]. The question, then, is why does this not occur?
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ventilatory activity results in active vasoconstriction in non-
working muscles. There is indeed evidence for this. As
observed in exercise, increased metabolic activity of muscles,
including respiratory muscles, leads to increased afferent
nerve activity, which increases sympathetic activity and pro-
duces generalized vasoconstriction in areas of nonworking
muscle [18,49,50]. Mechanical ventilation by reducing venti-
latory muscle activity turns off this process.
Resting failed respiratory muscles is necessary for force
generation to recover. There is also evidence that mechanical
ventilation reduces ventilatory muscle injury [51,52]. How-
ever, there may be a very important price to pay for this rest.
Nerve activity provides an important trophic stimulus to
muscles [8,53-58]. As anyone who has suffered a broken
limb that required immobilization knows, when a muscle is
inactive there is a rapid loss of muscle mass and force. This is
also true for ventilatory muscles, and their muscle loss may
even be more rapid than occurs in limb muscles. Animals that
are maintained under complete ventilatory support for as few
as 12 hours have a reduction in the force production of the
diaphragm both in vivo and in vitro, and this loss progresses
with increasing lengths of ventilator support [59,60]. The
process is associated with loses of muscle proteins and
changes in gene expression [61-63], a shift in muscle fibre
type from fast to slow twitch fibres, and an increase in the
embryonic form of the acetylcholine receptor. The process is
more difficult to demonstrate in human, but it was recently
and convincingly demonstrated that humans who are
mechanically ventilated and have no spontaneous efforts for 18
to 69 hours exhibit marked atrophy of their diaphragms [64].
In the animal studies the loss of diaphragmatic force is
markedly attenuated by allowing the animals to trigger the
ventilator [65]. It is therefore likely that efforts will be made to
allow at least some triggered activity as soon as possible in
ventilated critically ill patients. Strategies that use boluses of
narcotics and sedative drugs rather than drips and those that
avoid paralyzing agents unless absolutely necessary may help
to reduce the loss of ventilator muscle mass in ventilated
patients. An important deficiency in research in this area is
that, except for some measurements during the first 2 hours
of the restoration of spontaneous breathing, there are very
few data on the time course and magnitude of recovery of
force with resumed spontaneous ventilator efforts [66].
Intrinsic muscle dysfunction
As sepsis progresses it frequently becomes evident that
there is a failure of force generation by muscles and reduced
endurance in all muscles. This has immediate consequences
in ventilatory muscles (Figure 2a). Muscle dysfunction is
especially evident during episodes of fever and even occurs
with viral infections [67]. Bosczkowski and coworkers [68]
showed in rats that diaphragmatic force generation and
endurance decreased 3 days after the injection of Strepto-
coccus pneumoniae (Figure 2b). Because these animals
survived for 3 days, it is unlikely that shock itself accounts for
the diaphragmatic dysfunction. Indeed, arterial pressure and
blood gases were not significantly different between infected
and control animals. Furthermore, because the animals
breathed spontaneously, disuse atrophy also cannot explain
the muscle dysfunction. Based on electromyographic studies
in mechanically ventilated rats treated with endotoxin, Leon
and colleagues [69] concluded that the failure occurred at
the neuromuscular junction. In contrast, based on studies that
combined phrenic nerve activity and electromyographic
studies [20], as well as studies conducted in muscles of
animals that were curarized [70,71], Hussain and coworkers
[4] concluded that the failure occurs beyond the neuro-
muscular junction.
The cellular mechanisms for ventilator failure are still the
subject of speculation, and I discuss these processes here
only briefly, because they are reviewed elsewhere [3,4,7]. It is
most likely that multiple interacting factors play roles at
different time points. For example limitation of substrates
such as glycogen does not appear to be a factor early in
sepsis [24] but can become important [69] with sustained
inadequate perfusion and persistence of the catabolic state in
critically ill patients. Depletion of phosphate is associated
with muscle failure, and repletion can restore function [72].
However, in the initial phases of sepsis there more often
appears to be a failure to use substrates because there is
little evidence of substrate depletion.
Muscle dysfunction in sepsis is associated with evidence of
oxidative damage [73,74], and scavengers of reactive oxygen
species (ROS) reduce the loss of force [70] as well as
diaphragmatic dysfunction with mechanical ventilation [75].
Nitric oxide (NO), ROS such as superoxide and hydrogen
peroxide are thought to contribute to this process. The role
played by NO in the muscle dysfunction in sepsis is
particularly complex. NO is produced by nitric oxide syn-
thases (NOSs), of which there are three isoforms: NOS1 (or
neuronal type), NOS2 (or inducible type) and NOS3 (or
endothelial type). NOS2 has been found to be induced in the
rectus abdominus muscle of septic humans [76], but
inhibitors of NOS did not alter contractile responses in these
muscles. On the other hand, the addition of the toxic product
of NO and superoxide, peroxynitrite, to normal muscle did
decrease function, but this could be a nonspecific toxic effect
from an excess of this potent oxidant. In a subsequent study
the investigators found that NOS1 was decreased but NOS3
was increased in muscle samples from humans, but overall
constitutive NOS activity was reduced. In contrast, studies on
rats have tended to find an increase in NOS1 and NOS3
[77]. Importantly, the NOS isoforms have different locations
and thus could have local effects. NOS3 is present in blood
vessels and plays a role in regulating flow, whereas NOS1
plays a more prominent role in regulation transmission of
neural signals. NOS2 is widely distributed and could affect
Critical Care    Vol 13 No 1 Magder
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descriptive and thus have limited potential for determining the
role played by NO in the muscle failure of sepsis.
Inhibitors of NOS have been shown to lessen the decrease in
diaphragmatic force in endotoxic animals [77,78]. However,
studies of genetically manipulated mice that are deficient in
either NOS2 or NOS1 further confuse the picture, because
in these studies the presence of NOS was protective and the
absence of either NOS2 or NOS1 led to more muscle injury.
The important conclusion from these studies is that simple
pharmacological inhibition of NOS is unlikely to be a useful
therapeutic approach for respiratory muscle failure. Overall,
NO appears to be adding a regulatory component to under-
lying physiological processes. Maintenance of normal cell
integrity and force generation by a muscle requires the pro-
duction of energy-rich molecules such as ATP by the mito-
chondria. Mitochondria fail when there is inadequate oxygen
delivery, but they also fail in sepsis with adequate oxygen
delivery [79,80], indicating direct suppression by chemical
mediators or toxins in what is called ‘cytopathic hypoxia’
[81,82]. This could occur through direct actions of cytokines
such as tumour necrosis factor (TNF)-α on mitochondria [83],
or indirectly through increased oxidative stress, which could
come from increased nitrosylation products due to increased
production of NO and the formation of peroxynitrite [79,80,
84-86] as well as increased production of ROS [87] by
xanthine oxidase [88], NADPH oxidase [88,89], or prosta-
glandins [90,91].
Mitochondrial depression as a cause of muscle failure might
be expected to be associated with depletion of intracellular
ATP. This has been observed in skeletal muscles of rats in
some studies, but to a smaller extent than seen in the liver
[80], and is not observed in all studies [92]. However, the
concentration of ATP is not a good guide to the role of
bioenergetic failure because even when there is a marked
increase in consumption of ATP, as occurs during normal
exercise, the concentration of ATP usually stays constant.
This indicates that the real issue is production relative to
need, which is experimentally very difficult to assess. The
more useful measure is probably maximal ATP production,
which has been shown to be reduced in sepsis [92],
indicating that the failure of production to match needs is a
likely factor.
Based on the evidence in animals that ROS scavengers can
reduce diaphragmatic dysfunction is sepsis [70,71] as well
as diaphragmatic dysfunction in mechanically ventilated
patients [75], it has been proposed that the use of oxygen
radical scavengers might be of potential therapeutic value for
the treatment of ventilatory muscle dysfunction in humans.
The problem with this reasoning is that it has become
apparent that the redox state of the cell plays an important
role in regulating intracellular events [93,94] and ROS are
particularly important for cytokine signalling and growth
factors. The redox-sensitive signalling of cytokines occurs
through regulation of the activity of nuclear factor-κB (NF-κB)
[95,96] and alteration in redox state has positive and negative
effects on NF-κB activity. It has also become apparent that it
is not simply oxygen radicals that are important but the redox
state of all ROS, of which oxygen radicals are only a tiny
fraction [97,98]. Furthermore, the redox environment of the
cell is highly compartmentalized, with major differences
between the cytoplasm and nucleus, as well as probably in
the cytoplasm itself [99]. It is possible that positive results
with ROS scavengers on diaphragmatic function that were
observed in short-term animal experiments [70,71,100] were
related to the modification of these signalling pathways, but it
is difficult to predict what would happen when these
substances are used to alter the intracellular milieu in the
complexity of the critically ill patient. Therapeutic approaches
should try to ‘regulate’ and not ‘obliterate’!
As time progresses, a substantial proportion of the decrease
in muscle force production in sepsis is related to a decrease
in muscle mass, which can occur in less than 48 hours [92].
Sepsis is associated with abnormal protein metabolism,
which is part of an overall strategy that redirects metabolic
pathways to factors that are required to deal with the
inflammatory response [101]. Because skeletal muscle is the
largest repository of protein in the body, it is not surprising
that proteins from muscles, including ventilatory muscles, are
broken down to provide amino acids for molecules needed in
the inflammatory response. A major cytokine in the sepsis
cascade is TNF-α. This cytokine produces an immediate
decrease in contractile function that is not due to altered
calcium transits, indicating direct alteration in contractile
proteins [102]. It is well recognized that TNF-α causes
muscle wasting in inflammatory processes and cancer, and
was actually originally called ‘cachexin’ [103]. TNF-α
increases breakdown of myosin heavy chains in muscle cells
in culture, which is evident as atrophy in muscles of intact
animals [104]. Intracellular signalling for TNF-α occurs
primarily through NF-κB [105]. Because NF-κB is also a key
signalling molecule for IL-1 and endotoxin [106], it would not
be surprising that the muscle breakdown with these sub-
stances [69,71,107,108] also occurs through NF-κB. Activa-
tion of NF-κB by TNF-α increases muscle-specific ring-finger
protein 1 (MuRF1), which is known to cause muscle wasting
[109]. TNF-α also produces insulin resistance and decreases
insulin-like growth factor-1. The consequence of this is
decreased activity of the threonine serine kinase Akt, which is
a key switch in the cell that controls paths leading to either
protein production or breakdown, because Akt is activated by
insulin and insulin-like growth factor-1. Akt activates the
mammalian target of rapamycin, which is a key regulator of
intracellular protein production. It also phosphorylates the
forkhead box O (FOXO) transcription factor, which prevents
its migration to the nucleus. When allowed to go to the
nucleus, FOXO increases the transcription of atrophic genes
including Atrogen-1 and Murf-1 [109-111].
Available online http://ccforum.com/content/13/1/202
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mRNA, a key regulator of expression of the skeletal muscle
differentiation programme; this could impair the repair and
restoration of muscle proteins when degradation has been
accelerated. Inhibition of NF-κB prevents protein breakdown
in isolated myotubes [112] and reduces atrophy after
unloading of muscle [109]. Based on these types of studies,
it has been suggested that a therapeutic option is to inhibit
NF-κB to prevent muscle wasting in sepsis and preserve
ventilatory muscle function. I predict that this is unlikely to be
successful in humans because of the broad role that NF-κB
plays in the overall inflammatory response, including the
production of many molecules that help to turn off the
inflammatory response.
There is an important potential interaction between ventilator-
associated muscle loss and sepsis. As already discussed,
decreasing neural activity results in cellular alterations that
lead to protein loss and changes in the phenotype of the
muscles, as well as increased expression of proteins involved
in the skeletal muscle differentiation programme, including
MyoD and Myogenin [55,57,58]. These are potentially impor-
tant for the repair process. TNF-α, on the other hand, inhibits
production of MyoD through an NF-κB dependent pathway
[113]. This could amplify ventilator-associated ventilatory
muscle dysfunction.
Heart-lung interactions
Changes in the ventilatory pattern with sepsis have
implications for heart-lung interactions [40]. Because
dynamic compliance is decreased in sepsis, inspiratory effort
must be greater for the same tidal volume and consequently
pleural pressure swings for each breath must increase. The
inspiratory fall in pleural pressure lowers the environment of
the heart relative to the rest of the body, and consequently
increases the gradient for venous return during the inspiratory
effort (Figure 4a). Because the normal gradient for the return
of blood to the right heart is only in the range of 3 to 6 mmHg
[41,114], increased inspiratory swings can have a substantial
effect on the flow of blood back to the heart. Of importance,
there is a limit to this effect. When the pressure inside veins
falls to below the surrounding pressure, soft walled veins
collapse and the gradient for the return of blood is then from
the upstream pressure to the site of the collapse. This is
known as a vascular waterfall [115]. In a spontaneously
breathing person collapse of veins occurs when venous
pressure falls below atmospheric pressure but in a ventilated
patient collapse occurs when venous pressure falls below the
pleural pressure, which is above atmospheric pressure [116].
Because of the vascular waterfall, the effect of inspiration on
venous return is very dependent upon the initial right atrial
pressure. In a healthy person, right atrial pressure is either
below or close to the collapse pressure so that inspiratory
increases in right heart filling are small. However, in a patient
who has been excessively volume resuscitated, the inspira-
tory increase in venous return can be substantially increased
(Figure 4b). Furthermore, there is an important series effect
on the right and left heart. The increase in right heart filling
with inspiration must be passed to the left heart. If left heart
function is decreased, especially its diastolic function, then
swings in left atrial pressure can be considerably exag-
gerated. When this is associated with increased capillary
permeability, as typically occurs in sepsis, these swings in left
atrial pressure will further contribute to pulmonary oedema.
This will further decrease dynamic pulmonary compliance,
which will result in greater negative swings in pleural
pressure and add another positive feedback loop. Of
importance, the mean cardiac output itself will not give an
indication of the process; the process can only be identified
by looking at the magnitude of the inspiratory swings on the
central venous tracing or pulmonary artery occlusion pressure
if it is being measured [117] or by stroke volume measure-
ments by Doppler.
The increased fall in pleural pressure also has an effect on left
ventricular ejection, because it means that the left heart must
start its contraction from a more negative value and the left
heart thus effectively has a greater afterload [118,119]. If the
left heart starts with an elevated diastolic filling pressure and
is thus on the steeper portion of its diastolic filling curve, then
the increase in venous return with inspiration will result in
large increases in left ventricular diastolic pressures and
consequently a large increase in pulmonary capillary
pressure, which will also lead to more pulmonary leak.
Another factor that can contribute to swings in cardiac filling
pressures during the ventilatory cycle is active contraction of
abdominal muscles during expiration. Normally, expiration is
passive, but patients with lung injury, intra-abdominal sepsis,
or altered sensorium often have forced expiratory efforts. This
action increases abdominal pressure during expiration and
can result in increased venous return during these contrac-
tions and further exaggerate the oscillatory pattern in cardiac
filling pressures.
The inspiratory increase in venous return described above
can only occur if the heart is functioning on the ascending
part of the cardiac function curve. If the heart is functioning
on the flat part of the curve, venous return cannot increase
nor does the cardiac filling pressure increase relative to
atmosphere (Figure 4c). However, the filling pressure across
the wall, that is the transmural pressure, can increase
substantially and this can affect coronary flow and the
interaction of the left and right ventricles.
As ventilatory muscle function deteriorates in sepsis the
inspiratory effects on venous return will decrease, but when
the patient requires mechanical ventilation a new set of
problems emerges. Now with each breath there is a decrease
in venous return and an increase during the expiratory phase
(Figure 4d). If the breaths are triggered, the effects from the
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also active abdominal muscle contraction during expiration,
the expiratory increase in venous return will exaggerate the
swings in filling pressures (Figure 4e).
A further problem arises when increasing amounts of PEEP
are required. This increases the proportion of the lung in
West zone II, especially during the inspiratory phase. In
regions of the lung where this occurs, the downstream
pressure for flow is the pressure in the alveolus, and the
increase in this pressure can result in a large reduction in flow
through the lungs during this phase of the ventilator cycle
[120,121]. This will also contribute to an oscillatory pattern in
cardiac filling pressures and flow, and could contribute to
capillary leak. On the other hand, the rise in pleural pressure
with PEEP inhibits venous return and can potentially help
‘decompress’ over-filled ventricles. When cardiac output
decreases because of an increase in pleural pressure, there
is reflex constriction of capacitance vessels as well as fluid
retention by the kidney that increases venous pressures and
helps restore venous return and cardiac output [122].
However, when the patient recovers and mechanical
ventilation is withdrawn, removal of the positive pressure
allows increased venous return and an increase in cardiac
filling pressures. If ventricular function is adequate then the
increase in return volume will be successfully handled, but if
ventricular function is inadequate this can marked increase
cardiac filling pressures and lead to pulmonary oedema and
ventilatory failure [123]. To avoid this problem it is important
that mechanical support be progressively decreased and
excess vascular volume removed by diuresis before
extubation. In patients who are very fragile, it may sometimes
be necessary before extubation to diurese them to a point
where they are pre-renal, because otherwise they may have
sufficient volume for adequate cardiac output on the
ventilator but too much for off the ventilator.
Conclusion
Pulmonary abnormalities are common in septic patients, and
if ventilation is not supported ventilatory failure is potentially
an early cause of death. It is important to consider how the
general septic state interferes and limits ventilatory muscle
function, but also how abnormal ventilatory muscle function
interacts with other body systems, especially the
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Figure 4
Ventilatory effects on the relationship between cardiac function and venous return at different potential stages in sepsis. Cardiac function is
indicated by curved lines, and venous return by straight lines. (a) With spontaneous breaths the pressure around the heart falls relative to
atmospheric pressure, which is represented by a leftward shift of the cardiac function curve. Under basal conditions the cardiac function curve
intersects the venous return curve near the plateau of the venous return curve, so that the leftward shift produces only a small or no increase in
right heart filling with inspiration. (b) If the right atrial pressure starts from a higher value and the fall in pleural pressure is increased because of
changing pulmonary mechanics, then the inspiratory increase in right heart stroke volume is increased. (c) If the heart is functioning on the plateau
of the cardiac function curve, there is no increase in right heart filling with inspiration. However, there is an increase in the transmural pressure
(pressure across the wall) of the heart. (d) When a patient is ventilated with positive pressure, inspiration moves the cardiac function curve to the
right. There is thus an inspiratory fall in right ventricular stroke volume and a rise in venous pressure, which can affect upstream organs such as liver
and kidney. (e) The reduction in cardiac output with continuous positive pressure can be reversed by giving volume, which shifts the venous return
curve to the right (dark circle). However, when positive pressure is removed this will result increased cardiac filling, and if the left ventricle does not
handle the increased flow (open circle) pulmonary oedema may result. Pra, right atrial pressure; TM, transmural pressure.cardiovascular system. In patients who are ill for prolonged
periods of time, it important to consider the progressive
weakening of the ventilatory pump, which then must face
increased loads because of resolving lung injury. Proper
management of these patients requires a good understanding
of all of the pathophysiological factors involved.
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